Publications

Related Pages
References
    • Jong EC, Wasserheit JN, Johnson RJ, Carberry WL, Agosti J, Dunning S, Clark H. Praziquantel for the treatment of Clonorchis/Opisthorchis infections: report of a double-blind, placebo-controlled trial. J Infect Dis 1985;152:637-40.
    • Yangco BG, De Lerma C, Lyman GH, Price DL. Clinical study evaluating efficacy of praziquantel in clonorchiasis. Antimicrob Agents Chemother 1987;31:135-8.
    • Liu YH, Wang XG, Gao P, Ming-xin Q. Experimental and clinical trial of albendazole in the treatment of clonorchiasis (Clonorchis) sinensis. Chin Med J (Engl) 1991;104:27-31.
    • Guoqing L, Xiaozhu H, Kanu S. Epidemiology and control of Clonorchiasis sinensis in China. Southeast Asian J Trop Med Public Health. 2001;32 Suppl 2:8-11.
    • Papachristou GI, Schoedel KE, Ramanathan R, Rabinovitz M. Clonorchis sinensis-associated cholangiocarcinoma: a case report and review of the literature. Dig Dis Sci. 2005 Nov;50(11):2159-62.
    • Chai JY, Murrell KD, Lymbery AJ. Fish-borne parasitic zoonoses: status and issues. Int J Parasitol 2005; 35:1233-1254.
    • Keiser J, Utzinger J. Emerging Foodborne Trematodiasis. Emerging Infectious Diseases 2005; 11:1507-1514.
    • Rim HJ. Clonorchiasis: an update. J Helminthol. 2005 Sep;79(3):269-81.
    • Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005 Jan;5(1):31-41.
    • Ben-Menachem T. Risk factors for cholangiocarcinoma. European Journal of Gastroenterology and Hepatology 2007, 19:615-617.
    • Lim JH, Kim SY, Park CM. Parasitic diseases of the biliary tract. Am J Roentgenol 2007;188:1596-1603.
    • Rana SS, Bhasin DK, Nanda M, Singh K. Parasitic infections of the biliary tract. Curr Gastroenterol Rep 2007; 9:156-164.
    • Keiser J, Utzinger J: Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol 2007; 23:605-612.
    • Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 2008; 21:523-530.
    • Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev 2009; 22:466-483.
    • Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol 2010;73:197-230.
    • Shin H, et al. Epidemiology of cholangiocarcinoma: An update focusing on risk factors. Cancer Sci 2010; 101: 579-585.
    • Soukhathammavong P, Odermatt P, Sayasone S, Vonghachack Y, Vounatsou P, Hatz C, Akkhavong K, Keiser J. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis 2011; 11:110-8.
    • Doanh P, Yukifumi N. Clonorchis sinensis and Opisthorchis spp. in Vietnam: current status and prospects. Trans R Soc Trop Med Hyg 2016; 110: 13-20.
    • Feng M, Cheng X. (2017). Parasite Associated Cancers (Blood Flukes/Liver Flukes). In Q. Cai, Z. Yuan, K. Lan (Eds.), Infectious Agents Associated Cancers: Epidemiology and Molecular Biology (pp.193-205). Singapore: Springer Singapore.
    • Hughes T, et al. Opisthorchiasis and cholangiocarcinoma in Southeast Asia: unresolved problem. International Journal of General Medicine 2017; 10: 227-237.

    Back To Top

Page last reviewed: February 20, 2018
Content source: Global Health, Division of Parasitic Diseases and Malaria